Testo 400 Testosterone Blend 400 mg/ml

• Testo 400 – Royal Pharmaceuticals (400 mg/ml Testosterone Blend)
• Category: Injectable Testosterone Blend (Research Only)
• Brand: Royal Pharmaceuticals
• Concentration: 400 mg/ml total testosterone esters
• Packing: 10 1 ml ampoules
• Origin: United Kingdom
• Use Notice: Laboratory research and analytical applications only – not for human or veterinary administration.

What Is Testo 400?

Testo 400 is a high-strength oil-based testosterone blend containing 400 mg/ml of testosterone ester prodrugs. After intramuscular injection, esterases gradually convert these esters into free testosterone, making it a standard reference compound in androgen-receptor studies, pharmacokinetics, and doping-analysis research.

Because the exact ester composition is not stated on the label, the material is catalogued as “Testosterone blend, 400 mg/ml (mixed esters)”.

Mechanism of Action (Testosterone Esters)

Prodrug activation

Each ester (e.g., enanthate, cypionate, decanoate, etc.) becomes active testosterone only after enzymatic cleavage. The oil depot slows release, producing a multi-day to multi-week exposure curve depending on ester length.

Androgen receptor signalling

• Released testosterone diffuses into cells
• In some tissues converts to DHT
• Binds to intracellular androgen receptors
• Hormone–receptor complex regulates androgen-responsive genes

This results in increased protein synthesis, nitrogen retention, erythropoiesis, and modulation of androgen-dependent metabolic pathways.

Research Context & Applications

• Analytical chemistry: calibration standards for LC-MS/MS, GC-MS and HPLC testosterone detection
• Release-profile modelling: ester hydrolysis rate and depot-release kinetics
• Androgen-receptor studies: receptor binding, transcriptional response, cross-talk with other hormonal pathways
• Anti-doping research: development of detection windows for exogenous testosterone

These applications refer strictly to laboratory and analytical use.

Expected Research-Level Observations

• Rise in free and esterified testosterone concentrations over extended periods
• Measurement of testosterone DHT and testosterone estradiol metabolic pathways
• Changes in androgen-responsive gene expression in cellular models
• Modulation of nitrogen balance and erythropoietic markers in experimental models

Safety Profile & Potential Adverse Effects (Testosterone Class)

Endocrine & Reproductive

• Suppression of LH/FSH
• Reduced endogenous testosterone production
• Decreased spermatogenesis and testicular atrophy

Cardiovascular & Haematological

• Increased hematocrit / polycythaemia
• Adverse lipid shifts (HDL, LDL)
• Possible elevation in blood pressure

Androgenic Effects

Acne, oily skin, male-pattern hair loss

Virilisation in female exposure

Psychological & Neurologic

Mood change, irritability, aggression

Hepatic Considerations

Low intrinsic hepatotoxicity compared with 17--alkylated orals

Liver enzymes may still fluctuate under certain conditions

These points derive from known properties of testosterone esters and are provided for scientific completeness.

Compliance & Legal Status

Testosterone and its esters are controlled substances or prescription-only medications in most jurisdictions.

Listed under WADA S1 “Anabolic Agents” — prohibited at all times.

Product is supplied strictly for laboratory, analytical, and research use only.

Technical Data Table

Intended Use

Research, analytical method development

For laboratory and research use only. Not for human or veterinary administration.